A statistically significant association exists between efavirenz for initial HIV therapy and the risk suicidality. When this drug is given as a component of an antiretroviral drug regimen, patients should be monitored carefully for the possibility of deterioration of their depression or evidence of suicidal behavior.
Optimal timing for Starting Antiretroviral Therapy in HIV-Infected Patients with Cryptococcal Meningitis
Physicians who treat patients with cryptococcal meningitis in untreated AIDS patients should be aware that early initiation of antiretroviral therapy is associated with increased mortality.
New recommendations for HIV testing in laboratories will lead to HIV diagnosis as much as 3 to 4 weeks sooner, according to the CDC.
Finding a good doctor to manage HIV probably matters a lot, but finding a good doctor, or any useable or reliable information about a particular doctor, is almost impossible. Here: 5 tips on finding a good HIV physician.
Women of all races and ethnicities are less likely to take antiretroviral therapy than men. Consideration of both gender and race/ethnicity is thus needed to identify areas for targeted intervention to improve outcomes relevant to specific groups of women."
The tools exist to eliminate HIV, but non-adherence is common. New evidence suggests that triggered reminders can influence adherence rates in HIV-positive patients.
HIV-positive patients have about double the usual risk of kidney disease. Here, detailed guidance on how to monitor for and manage it in this population.
CDC has finalized its guidelines on use of pre-exposure prophylaxis for HIV, which have been well-received and may ease some concerns. But the new public health strategy still faces hurdles.
There are many reasons why people infected with HIV are more likely to be smokers, and the condition makes it a challenge to quit. But many do want to stop smoking, and a new program shows how to tailor the effort for them.
(Podcast) Two years ago, two HIV-positive patients lost all signs of the virus, as far as doctors at Harvard Medical School could tell. Suddenly, months later, the virus returned in force. What happened, and what does it mean?
Despite a revolution in treatment options for hepatitis C, many physicians are taking a wait-and-see approach, hoping even newer medications may have a lower price tag.
Many primary care doctors do not test every adult for HIV (as guidelines mandate), perhaps uncertain what to do or say afterwards. Here, from three experts, simple words of advice.